Document is current
Any future updates will be listed below
-
Authors
Aria, Francesca
Arp, Christopher J.
Prikas, Emmanuel https://orcid.org/0000-0001-8833-2728
Goodwin-Groen, Sebastian
Pandey, Kiran https://orcid.org/0000-0001-8658-2942
Munari, Leonardo
Patel, Shlok
Trauner, Dirk
Alberini, Cristina M. https://orcid.org/0000-0001-7386-0018
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH065635)
- License Information
-
More Information
Article History
Received: 23 May 2024
Revised: 1 August 2025
Accepted: 1 September 2025
First Online: 30 October 2025
Competing interests
: CMA, CJA, and DT are inventors of patents filed by NYU on the use of IGF2 receptor agonist ligands for the treatment of Angelman syndrome and autism and of memory and cognitive impairments. The other authors declare no competing interests.
